Skip to main navigation menu Skip to main content Skip to site footer

← Return to Article Details Download Download PDF

BREAKTHROUGH THERAPIES IN TYPE 2 DIABETES: ADVANCED ROLE OF GLP-1 RECEPTOR AGONISTS AND SGLT2 INHIBITORS